Stock futures are mostly flat this morning as traders brace for the outcome of the Federal Reserve’s upcoming rate decision. Sentiment remains cautious after recent volatility in global bonds and a sharp yield spike. Many investors have parked money in safer, liquid assets as money-market funds saw a significant inflow.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
At the same time, there are pockets of optimism. Shares of Nvidia are on the rise as markets cheered news that its H200 AI chips got approval for exports to China, helping fuel modest gains in chip and semiconductor peers as well.
With the Fed meeting just ahead, many traders seem to be in “wait-and-see” mode. Volatility could emerge sharply depending on the tone of the decision and forward guidance.
In pre-market trading, S&P 500 futures fell 0.04%, Nasdaq futures fell 0.14% and Dow futures fell 0.03%.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- CVS Health (CVS) up 3% after raising its FY25 outlook and initiating FY26 guidance ahead of its investor day
- Nvidia (NVDA) up 1% after President Trump said on social media that the U.S. will allow the company to ship its H200 artificial intelligence chips to “approved customers” in China and elsewhere
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
LOWER –
- GeoPark (GPRK) down 12% after Parex Resources (PARXF) announced that it has halted discussions with the company regarding the acquisition of GeoPark by Parex
- SLM (SLM) down 12% after presenting an updated medium-term outlook at its investor forum
- Home Depot (HD) down 2% after reaffirming its FY25 guidance and providing a FY26 outlook ahead of its investor conference
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS Health Unveils Strategic Vision at Investor Day
- CVS Health announces new technology products, services offering
- CVS Health raises FY25 adjusted EPS view to $6.60-$6.70 from $6.55-$6.65
- CVS Health sees FY26 adjusted EPS $7.00-$7.20, consensus $7.16
- CVS Health sees mid-teens Adjusted EPS CAGR through 2028